Funded Startups in Hawthorne
Disclosed funding in Hawthorne is led by a single outlier: Skyryse’s $300M Series C on 2026-02-03 dwarfs the rest of the list, where the next-largest discl…
Disclosed funding in Hawthorne is led by a single outlier: Skyryse’s $300M Series C on 2026-02-03 dwarfs the rest of the list, where the next-largest disclosed rounds are Hadrian at $131M (2026-01-09) and Superior Biologics at $136M, both well below Skyryse. Most other disclosed amounts cluster under $50M, including Critical Energy’s $19M (2026-06-17), Vital Lyfe’s $18M (2025-12-16), and Allstar Innovations’ $44M (2023-09-14).
The 13 most recent rounds span 2020-07-22 (Swoop) through 2026-06-17 (Critical Energy). A tight temporal concentration appears in late 2025 and early 2026, with several Hawthorne-based Seed rounds and large-ticket activity: Andrenam ($10M) on 2025-06-16, Vital Lyfe ($18M) on 2025-12-16, and two major events in January–February 2026 (Hadrian $131M on 2026-01-09; Skyryse $300M on 2026-02-03). Geographically, 11 of 13 rows cite Hawthorne, California; the remaining two are Hawthorne, New York (Superior Biologics, $136M on 2022-12-01) and a mix of smaller Hawthorne/sector entries all using the Hawthorne, California label.
Most recent rounds
13 shownRelated listings
Frequently asked
Which round is the standout outlier, and how does it compare to the next-largest disclosed amounts on this list?
Skyryse’s $300M Series C closed on 2026-02-03 is the only disclosed round in this set above $100M. The next-largest disclosed amounts are Superior Biologics at $136M (2022-12-01) and Hadrian at $131M (2026-01-09), both substantially below $300M.
Do the most recent dates cluster, or are they evenly spread across 2020–2026?
They cluster around late 2025 to early 2026: Seed rounds include Andrenam at $10M (2025-06-16) and Vital Lyfe at $18M (2025-12-16), followed by Hadrian at $131M (2026-01-09) and Skyryse at $300M (2026-02-03). The earliest row shown is Swoop on 2020-07-22, so activity is weighted toward the most recent window.
Is Hawthorne, California over-represented versus other geographies despite the same city name?
Yes. 11 of the 13 rows list Hawthorne, California, including Skyryse ($300M on 2026-02-03) and Critical Energy ($19M on 2026-06-17). The two non-California entries are both tied to the same city name but different state: Superior Biologics is listed as Hawthorne, New York with $136M on 2022-12-01.
What does the stage mix suggest—how much is concentrated in Seed versus other categories (including blanks)?
Seed appears 3 times on the 13 rows: Critical Energy ($19M, 2026-06-17), Vital Lyfe ($18M, 2025-12-16), and Andrenam ($10M, 2025-06-16). One additional named stage appears (Skyryse as Series C for $300M on 2026-02-03), while several rows use “Series Unknown” (including Landline $3M on 2025-07-10 and Allstar Innovations $44M on 2023-09-14).
Are there other notable funding outliers besides the $300M event?
Yes, but less extreme. Hadrian’s $131M (2026-01-09) and Superior Biologics’ $136M (2022-12-01) sit at the top tier below Skyryse, while multiple rounds are far smaller, such as hegelt at $100K (2020-12-01) and Landline at $3M (2025-07-10).
Which sectors show up most often in this Hawthorne set?
Manufacturing appears repeatedly: Hadrian ($131M, 2026-01-09), Vital Lyfe ($18M, 2025-12-16), and Epirus ($70M, 2020-12-17) are all labeled Manufacturing. Science and Engineering also repeats with DASH Systems ($8M, 2020-12-16) and hegelt ($100K, 2020-12-01).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.